[Fibrinolytic factors: novel molecular targets for cytokine storm-associated diseases]

Koichi Hattori1,2, Hiroshi Shimazu3, Satoshi Takahashi4

  • 1Center for Genomic & Regenerative Medicine, Juntendo University Graduate School of Medicine.

Insights

Understanding the cytokine storm in severe COVID-19 reveals the fibrinolytic system

Area of Science:

  • Immunology
  • Pathophysiology
  • Vascular Biology

Background:

  • The severe coronavirus disease 2019 (COVID-19) has caused millions of deaths globally.
  • The "cytokine storm," driven by the coagulation/fibrinolytic system, significantly contributes to COVID-19 pathology.
  • Endothelial cells play a crucial role in modulating inflammatory and coagulation factors.

Purpose of the Study:

  • To elucidate the role of the fibrinolytic system in inflammatory diseases, particularly COVID-19.
  • To explore potential therapeutic targets within the angiocrine and fibrinolytic systems for managing inflammatory conditions.

Main Methods:

  • Review of existing research on the pathophysiology of COVID-19.
  • Focus on the mechanisms of the cytokine storm and vascular endothelial damage.
  • Analysis of the fibrinolytic system's involvement in inflammatory disease progression.

Main Results:

  • The coagulation/fibrinolytic system is central to the "cytokine storm" observed in severe COVID-19.
  • Vascular endothelial damage destabilizes the angiocrine system, exacerbating inflammation.
  • Imbalanced angiocrine factors and cytokines are key contributors to COVID-19 complications.

Conclusions:

  • The fibrinolytic system is a significant factor in the pathophysiology of inflammatory diseases like COVID-19.
  • Targeting angiocrine and fibrinolytic factors presents a promising avenue for novel therapeutic strategies.
  • Further research into these pathways could lead to effective treatments for severe COVID-19 and related inflammatory conditions.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
243
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K